Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000156912 | SCV000206633 | uncertain significance | not specified | 2016-04-26 | criteria provided, single submitter | clinical testing | proposed classification - variant undergoing re-assessment, contact laboratory |
Gene |
RCV000869575 | SCV000531383 | likely benign | not provided | 2020-11-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001456331 | SCV001660109 | likely benign | Dilated cardiomyopathy 1CC; Hypertrophic cardiomyopathy 20 | 2024-12-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002444647 | SCV002682528 | likely benign | Cardiovascular phenotype | 2021-09-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Blueprint Genetics | RCV000157392 | SCV000207130 | uncertain significance | Primary dilated cardiomyopathy | 2014-08-05 | no assertion criteria provided | clinical testing |